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The peptide Boc-Cmethylene Glu-Glu-Val has been synthesized and shown to be a strong inhibitor of the 
vitamin K-dependent carboxylation catalyzed by a detergent solubilized rat liver microsome preparation. 
The inhibition is apparently competitive with respect o the substrate peptide and non-competitive with 
respect o HCO; 
Vitamin K Carboxylation I-Methylene glutamic acid y-Carboxyglutamic acid 
1. INTRODUCTION mM). In contrast, y-fluoroglutamic acid-contain- 
Vitamin K is an essential coenzyme in a post- 
translational reaction which carboxylates selected 
glutamyl residues in precursor proteins to convert 
them to the y-carboxyglutamyl residues of com- 
pleted proteins [l-3]. A detergent solubilized 
microsomal preparation from rat liver is able to 
carboxylate small synthetic peptides containing L- 
glutamic acid and reproducing part of the pro- 
thrombin precursor [4-61. 
ing peptides have been prepared and shown to be 
substrates and not inhibitors for the vitamin K- 
dependent carboxylation reaction [9]. 
We report here the results obtained with a pep- 
tide containing a 4-methylene glutamic acid re- 
sidue, which was expected to react eventually with 
a nucleophilic site of the carboxylase. 
2. EXPERIMENTAL 
Modifications of the glutamyl residues are im- 
portant for studies related to the elucidation of the 
carboxylation mechanism, and may afford specific 
inhibitors directed towards the glutamyl binding 
site of the carboxylase. Authors in [7] have re- 
ported the synthesis of a peptide containing 
residues of 0-phosphoserine which competitively 
inhibits the carboxylation of Phe-Leu-Glu-Glu- 
Leu with an affinity constant close to that of the 
reference peptide (Ki = 4 mM). Recently, it has 
been reported [S] that a pentapeptide containing 
(2S,4S)-4-methylglutamic acid competitively in- 
hibited the carboxylase with a Ki of 65 /rM (I& = 
80 PM), while the (2S,4R)isomer-containing pep- 
tide was a much weaker inhibitor (I& = 3.6 
2.1. Peptide synthesis 
Proton NMR spectra were recorded on a Bruker 
WM 250-FT spectrometer. Chemical shifts are 
reported as ppm relative to tetramethylsilane. 
* TO whom correspondence should be addressed 
4-Methylene DL-glutamic acid was prepared by 
a modification of the method of [lo]. Resolution 
was achieved in a quantitative yield on the racemic 
ZV-acetyl derivative using hog kidney acylase I [ 111. 
4-Methylene L-glutamic acid I ([cy]? = 15.0”, c = 
1, 5 N HCI [121) was separated from the N-acetyl 
D-isomer by ion exchange chromatography on 
AGI-X4 resin (AcO- form) and esterified with 
HCI/MeOH to give the dimethyl ester derivative 
II. Treatment of II with di(t-butyl) dicarbonate 
(Fluka) in the presence of dimethylamino4- 
pyridine in acetonitrile-water (99: 1) gave the 
Boc-4-methylene L-glutamic acid dimethyl ester III 
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which was regioselectively hydrolyzed with LY- 
chymotrypsin to Boc-4-methylene L-glutamic acid 
y-methyl ester IV [13]. ‘H-NMR (CDCl3) :6 = 
1.42 (s, 9H, Boc), 2.70 (m, 2H, CH2), 3.75 (s, 3H, 
OMe), 5.68-6.20 (2s, 2H, CH2= ). Boc-glutamic 
acid y-methyl ester was obtained from the cor- 
responding dimethyl ester by the same method. IV 
was used for the synthesis of the protected peptide 
Boc4-methylene Glu-Glu-Val trimethyl ester using 
the liquid phase methodology as described in fig. 1. 
‘H-NMR (CDCl$:6 = 1.42 (s, 9H, Boc), 2.70 (m, 
2H,&CH2), 3.65, 3.71, 3.76 (3s, 9H, OMe), 5.70, 
6.25 (2s, 2H, CH2=). Final deprotection was ef- 
fected by mild alkaline hydrolysis. Boc4-methylene 
Glu-Glu-Val V was purified on a DEAE-Sephadex 
A-25 column with a linear gradient of acetic acid 
(0.5-4 N). [LY]~ = -32.2” (c = 0.6, H20). 
‘H-NMR (D20):6= 1 .O (d, 6H, 2 Me), 1.45 (s, 9H, 
Boc), 2.2-2.7 (3m, 6H, CH2), 4.0-4.5 (3m, 3H, 
Ha), 5.8, 6.32 (2s, 2H, CH2 =). The peptide was 
shown to be pure by thin-layer chromatography on 
silica gel 60 F-254 (solvent: butanol/acetic acid, 
4 : 1, saturated with water), high-pressure liquid 
COOH COOH 
(I) cm, (lr) 
(Ill) Boc-p+JH Val-OCH, 
I 0% I 
I VII 
Boc-4mothylom Olu - Glu-Val-OH 
bn AH 
(P) 
Fig. 1. Scheme for the synthesis of the peptide containing 
4-methylene glutamic acid. (i) HCI-MeOH, (ii) (Boc)zO- 
DMAP, (iii) cu-chymotrypsin, (iv) DCCI, (v) HCl- 
A&H, (vi) DCCI, (vii) 2 N LiOH/MeCN-Hz0 (1: 1). 
chromatography and high-voltage paper electro- 
phoresis at pH 4.0, 70 V. cm-’ (electrophoretic 
migration relative to Glu = 2.1). Analysis of the 
N-trifluoroacetyl O-isopropyl ester derivative of 
the peptide acidic hydrolysate by gas chroma- 
tography on a chiral phase (Chrompack XEdO-S- 
valine-S-phenylethylamide fused silica capillary 
column) [14] indicated an optical purity higher 
than 98% for the constitutive amino acids. 
2.2. Carboxylation assays 
Liver microsomes were prepared from vitamin 
K-deficient rats as in [lS]. The microsomal pellets 
were solubilized in SIKM buffer (0.25 M sucrose, 
SO mM imidazole, 0.6 M KCl, 15 mM MnC12) pH 
7.5, containing 1.5% Triton X-100, 1 mM NAD+ 
and 1 mM DTT. 0.1 ml of the solubilized prepara- 
tion (lo-15 mg proteins/ml), 50~1 peptide solution 
in SIKM, 2.5 ~1 of phylloquinone solution (12 
mg/ml) in 5% Triton X-100 and 2.5 ~1 of 1 mM 
DTT were incubated with agitation for 5 min, at 
20°C. The reaction was initiated with 25 ~1 of 
NaH14COj (6&i, 53 mCi/ mmol), carried out for 
30 min at 2O”C, and terminated by addition of 25 
~1 of 60% trichloroacetic acid. After centrifuga- 
tion, 150~1 of the supernatants were transferred to 
counting vials and dried in vacua over NaOH 
pellets during 2 h. Water (2 ml) and Instagel (14 
ml) were added and the radioactivity counted in a 
Packard liquid scintillation spectrometer. Micro- 
somal proteins were determined according to [16] 
with bovine serum albumin as standard. 
3. RESULTS AND DISCUSSION 
The peptide which was synthesized contained 
4-methylene glutamic acid in place of the first 
glutamyl residue of the Boc-Glu-Glu-Val substrate 
because it has been demonstrated, with several 
similar substrates, that only this residue was car- 
boxylated by the vitamin K-dependent carboxylase 
[15,17-191. Incidentally, peptides containing 
4-methylene glutamic acid residues have been ob- 
tained as chemical modification products of y- 
carboxyglutamic acid-containing peptides [20,21]. 
When Boc4-methylene Glu-Glu-Val was tested 
as a substrate for the carboxylase at 0.3 mM con- 
centration, no 14C02 incorporation was observed 
(table 1). When incubated in the presence of the 
usual substrate (Boc-Glu-Glu-Val) at the same con- 
266 
Volume 177, number 2 FEBS LETTERS November 1984 
Table 1 
Effect of Boc4-methylene Glu-Glu-Val on the carbox- 
ylation reaction 
Substrates Carboxylase activity 
dpm/mg % 
protein* 
Boc4-methylene Glu-Glu-Val 
(0.3 mM) 
Boc-Glu-Glu-Val (0.15 mM) 
Boc-Glu-Glu-Val (0.15 mM) 
+ Boc-4-methylene Glu-Glu- 
Val (0.15 mM) 
120 - 
10 030 100 
2 700 27 
*Incubation blanks without vitamin K subtracted 
(70-100 dpm/mg protein) 
centration (0.15 mM), our peptide inhibited its car- 
boxylation by 73%. However, the inhibition was 
not time dependent, nor was it increased by prein- 
cubation with the inhibitory peptide. The inhibi- 
tion was essentially reversible after dialysis of the 
resuspended microsomes for 1 h (table 2). All these 
results indicate that no covalent reaction of the 
methylene peptide with the carboxylase had occur- 
red. 
The double-reciprocal plot shown in fig.2 is con- 
sistent with the action of the methylene peptide as 
a reversible competitive inhibitor with respect to 
the peptide substrate, and the slope replot indicates 
a Ki of 50 ,uM, slightly lower than that measured 
for the 4-methyl glutamate-containing pentapep- 
tide [8]. 
Table 2 
Reversibility of the inhibition by Boc-6methylene Glu-Glu-Val 
Preincubation (20 min) Substrate Carboxylase activity after 
dialysisa 
dpm/mg protein % 
Without peptide Boc-Glu-Glu-Val (0.4 mM) 28 400 100 
With Boc4-methylene Glu-Glu-Val Boc-Glu-Glu-Val (0.4 mM) 26 900 95 
(0.2 mM) 
“After preincubation at 2O”C, solubilized microsomes were dialyzed for 1 h against the 
microsome resuspension buffer (see section 2), then used for the measurement of carboxylase 
activity 
One possible hypothesis for the high affinity of 
such inhibitors was their possible analogy with a 
‘transition state’ intermediate involving the enter- 
ing COZ molecule, which has been demonstrated to 
be the reactive carboxylic species [22]; in such a 
case, these compounds would be similarly com- 
petitive inhibitors with respect to COZ. No such 
data have been reported for the methyl glutamate- 
containing peptides. In an experiment with various 
Hr4COY concentrations, the methylene peptide 
behaved as a perfect non-competitive inhibitor 
- 
Fig.2. Double-reciprocal plot of the effect of 
Boc-4-methylene Glu-Glu-Val on the vitamin K- 
dependent carboxylation of Boc-Glu-Glu-Val at various 
peptide concentrations. Inhibitor concentration: 0 
(M), 0.05 mM (C--O), 0.1 mM (O-XI), 0.15 mM 
(M). A replot of the slopes is shown in the inset. 
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1 2 3 4 
l,‘(NaH CO,) , mM 
Fig.3. Double-reciprocal plot of the effect of Boc-C 
methylene Glu-Glu-Val on the vitamin K-dependent car- 
boxylation of Boc-Glu-Glu-Val (0.3 mM) at various 
HCOT concentrations. Inhibitor concentrations: 0 
(M), 0.05 mM (M), 0.1 mM (H), 0.15 
mM (c--o). 
(fig.3). We may thus conclude that the binding of 
the methylene peptide at the substrate site has no 
effect at all on the binding of COZ. At this mo- 
ment, no explanation is available for the high af- 
finity observed for this inhibitor. 
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